Not available
Quote | BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)
Last: | $1.36 |
---|---|
Change Percent: | -0.76% |
Open: | $1.32 |
Close: | $1.36 |
High: | $1.37 |
Low: | $1.32 |
Volume: | 22,721 |
Last Trade Date Time: | 09/06/2023 03:00:00 am |
News | BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)
BiondVax (NASDAQ: BVXV) , a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals...
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company, is pleased to announce today a change of its corporate name to Scinai Immunotherapeutics Ltd. (“Scinai ”). In the past two years, the Company ...
Message Board Posts | BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: Researchers ID Antivirals That Can Fight New Infectious Illnesses New research has | NetworkNewsWire | investorshangout | 05/05/2023 8:52:19 PM |
NetworkNewsWire: Study Shows that Skin Conditions May Indicate Presence of Rheumatic Disease New res | NetworkNewsWire | investorshangout | 05/01/2023 8:34:22 PM |
NetworkNewsWire: Three Data-Management Lessons that Healthcare Can Learn from Other Fields Data mana | NetworkNewsWire | investorshangout | 04/25/2023 8:42:02 PM |
NetworkNewsWire: BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aims to Complement its NanoAb Core Foc | NetworkNewsWire | investorshangout | 04/25/2023 8:07:43 PM |
NetworkNewsWire: Study Finds That Different Subtypes of Epilepsy Trigger Different Autoimmune Condit | NetworkNewsWire | investorshangout | 04/21/2023 10:21:35 PM |
News, Short Squeeze, Breakout and More Instantly...
BiondVax Pharmaceuticals Ltd. Company Name:
BVXV Stock Symbol:
NASDAQ Market:
BiondVax (NASDAQ: BVXV) , a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals...
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) , a biopharmaceutical company, is pleased to announce today a change of its corporate name to Scinai Immunotherapeutics Ltd. (“Scinai ”). In the past two years, the Company ...
BiondVax (NASDAQ: BVXV) , a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently recei...